Oncotelic Therapeutics Files Q1 2025 10-Q
Ticker: OTLC · Form: 10-Q · Filed: May 15, 2025 · CIK: 908259
| Field | Detail |
|---|---|
| Company | Oncotelic Therapeutics, Inc. (OTLC) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotech
TL;DR
**Oncotelic Therapeutics (ONCR) filed its Q1 2025 10-Q. Check financials.**
AI Summary
Oncotelic Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Mateon Therapeutics Inc. and Oxigene Inc., is based in Agoura Hills, CA. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Oncotelic Therapeutics' financial health and operational progress during the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, Oncotelic Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Oncotelic Therapeutics, Inc. (company) — Filer of the 10-Q
- Mateon Therapeutics Inc. (company) — Former company name
- Oxigene Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250515 (date) — Filing date
- 29397 AGOURA RD. #107 (address) — Business and mail address
- AGUORA HILLS, CA 91301 (address) — Business and mail city, state, zip
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on May 15, 2025.
What are the former names of Oncotelic Therapeutics, Inc.?
The company was formerly known as Mateon Therapeutics Inc. and Oxigene Inc.
What is the business address of Oncotelic Therapeutics, Inc.?
The business address is 29397 AGOURA RD. #107, AGUORA HILLS, CA 91301.
What is the Standard Industrial Classification code for Oncotelic Therapeutics, Inc.?
The SIC code is 2834, Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Oncotelic Therapeutics, Inc. (OTLC).